Seeing Is Believing

Currently out of the existing stock ratings of Yaron Werber, 130 are a BUY (72.63%), 48 are a HOLD (26.82%), 1 are a SELL (0.56%).
Analyst Yaron Werber, currently employed at TD COWEN, carries an average stock price target met ratio of 64.09% that have a potential upside of 22.77% achieved within 387 days.
Yaron Werber’s has documented 355 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on RARE, Ultragenyx at 02-Sep-2026.
Analyst best performing recommendations are on GMAB (GENMAB AS).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 7/17/2023. The price target of $533 was fulfilled within 3 days with a profit of $48.57 (10.03%) receiving and performance score of 33.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Jan-2025
$435
$-2.23 (-0.51%)
$400
Buy Since 01-Jan-2025
$457
$19.77 (4.52%)
$427
Buy Since 05-Feb-2023
$460
$22.77 (5.21%)
$400
Hold Since 22-Aug-2019
$352
$-85.23 (-19.49%)
$303
Hold Since 06-Oct-2024
$400
$-37.23 (-8.51%)
$350
Which stock is Yaron Werber is most bullish on?
Which stock is Yaron Werber is most reserved on?
What Year was the first public recommendation made by Yaron Werber?